Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

All Episodes

May 5, 2025 • 21 mins

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.

Related Content:

Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder

Mark as Played

Advertise With Us

Popular Podcasts

Stuff You Should Know

If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

24/7 News: The Latest

The latest news in 4 minutes updated every hour, every day.

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

.css-15opob5{left:0;position:absolute;top:0.8rem;} All Episodes

.css-14f5ked{margin:0;word-break:break-word;display:-webkit-box;-webkit-box-orient:vertical;box-orient:vertical;-webkit-line-clamp:2;overflow:hidden;}Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

Popular Podcasts

.css-r6mb8g{margin:0;word-break:break-word;display:-webkit-box;-webkit-box-orient:vertical;box-orient:vertical;-webkit-line-clamp:1;overflow:hidden;}Stuff You Should Know

24/7 News: The Latest

Dateline NBC

All Episodes

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

Stuff You Should Know